Search

Your search keyword '"Raithel H"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Raithel H" Remove constraint Author: "Raithel H"
110 results on '"Raithel H"'

Search Results

10. Pulmonary risk of intraoral surface conditioning using crystalline silica.

18. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos

19. Beispiele asbestfaserstaubbedingter Veränderungen im HRCT – Anhaltspunkte für die Kausalzuordnung bei Vorsorgeuntersuchungen und bei der gutachterlichen Beurteilung

20. Anzeigekriterien asbestfaserstaubbedingter Erkrankungen gemäß BK-Nr. 4103 BKV

21. Digitale Radiografie in der Untersuchung von arbeits- und umweltbedingten Lungen- und Pleuraerkrankungen

32. [Examples for asbestos-related findings in HRCT - criteria for the assessment of causal relationships in surveillance programmes and medical expert opinion].

33. [Recommendations for reporting benign asbestos-related findings in chest X-ray and CT to the accident insurances].

34. [Digital radiography in chest imaging of occupational and environmental lung diseases].

35. [Further development of the International Pneumoconiosis Classification--from ILO 1980 to ILO 2000 and to ILO 2000/German Federal Republic version].

36. [Findings in a high-risk group following asbestos exposure. Benefit of ENT examinations in patients with long-term exposure to asbestos].

37. Association between 8-hydroxy-2'-deoxyguanosine levels in DNA of workers highly exposed to asbestos and their clinical data, occupational and non-occupational confounding factors, and cancer.

38. Levels of 8-hydroxy-2'-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany.

39. The association of occupational asbestos dust exposure and laryngeal carcinoma.

40. [Asbestos dust-induced laryngeal carcinoma--a new occupational disease? Current scientific knowledge and social health regulations].

41. Biomonitoring of nickel and chromium in human pulmonary tissue.

43. Nickel-, chrom- and cobalt-concentrations in human tissue and body fluids of hip prosthesis patients.

44. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].

45. Increased content of chromium and nickel in lung tissues from patients with bronchial carcinoma.

46. Medical and toxicological aspects of occupational nickel exposure in the Federal Republic of Germany--clinical results (carcinogenicity, sensitization) and preventive measures (biological monitoring).

48. Quantitative determination of chromium and nickel in tumour and tumour-free human tissue.

49. [Toxicity and carcinogenicity of nickel and its compounds. A review of the current status (author's transl)].

Catalog

Books, media, physical & digital resources